Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
180.00    1.00 (0.56%)
Bid:
180.00
Ask:
184.00
Spread: 4.00 (2.222%)
Market Cap: £34.98m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Director Dealing

20 Oct 2022 12:03

RNS Number : 5781D
Palace Capital PLC
20 October 2022
 

20 October 2022

 

 

Palace Capital PLC

("Palace Capital", the "Company" or the "Group")

 

Director Dealing

 

Palace Capital announces that Matthew Simpson, Chief Financial Officer, today purchased 8,471 ordinary shares of 10p each at 236.094p per share.

 

For further information, contact:

PALACE CAPITAL PLC

Steven Owen, Interim Executive Chairman / Matthew Simpson, Chief Financial OfficerTel. +44 (0)20 3301 8330

 

Financial PR 

FTI Consulting

Dido Laurimore/ Giles Barrie

Tel: +44 (0)20 3727 1000

palacecapital@fticonsulting.com

 

About Palace Capital plc (www.palacecapitalplc.com)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew Simpson (Chief Financial Officer)

2

Reason for the notification

a)

Position/status

See 1 a) above

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Palace Capital plc

b)

LEI

2138009JDFQOXJFCJQ05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 Identification code

Ordinary shares of 10 pence each

 

Identification code (ISIN) for Palace Capital plc ordinary shares: GB00BF5SGF06

b)

Nature of the transaction

Acquisition of ordinary shares

c)

Price(s) and volume(s)

 8,471 ordinary shares at 236.094 pence per share

d)

Aggregated information

- Aggregated volume

- Price

 

8,471

236.094p

e)

Date of the transaction

20 October 2022

f)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFEIIALIFIF
Date   Source Headline
5th Mar 20212:22 pmRNSHolding(s) in Company
17th Feb 20212:43 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSUpdate on rent collection
21st Dec 202012:05 pmEQSHardman & Co Research: Q&A with Mike Foster on Palace Capital (PCA): Interim results on track - upside clear in FY'22
26th Nov 20208:00 amEQSPalace Capital (PCA): COVID-19 impacts actively managed
24th Nov 20205:20 pmEQSHardman & Co Research: Palace Capital (PCA): Interim results on track - upside clear in FY'22
17th Nov 20207:00 amRNSHalf-year Report
13th Nov 20207:00 amRNSInvestor Presentation
26th Oct 20203:00 pmRNSDirector/PDMR Shareholding
16th Oct 20202:09 pmRNSDirector Dealing
13th Oct 20207:00 amRNSUpdate on trading and rent collection
7th Oct 20203:40 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSHolding(s) in Company
2nd Oct 20207:00 amRNSHolding(s) in Company
2nd Oct 20207:00 amRNSReduction of Share Premium Account
15th Sep 20207:00 amRNSDividend Declaration
4th Sep 20202:00 pmEQSHardman & Co Research: Hardman Talks: Palace Capital interview with Mike Foster
7th Aug 20201:40 pmRNSResult of AGM
15th Jul 20201:55 pmRNSNotice of AGM
15th Jul 20207:00 amRNSGrant of awards under Deferred Bonus Plan
14th Jul 20203:05 pmEQSHardman & Co Research: Palace Capital (PCA): Encouraging full-year results
13th Jul 20207:00 amRNSDirector/PDMR Shareholding
9th Jul 20203:28 pmRNSDirector/PDMR Dealing
7th Jul 20202:52 pmRNSFinal Results for the year ended 31 March 2020
7th Jul 20207:00 amRNSFinal Results for the year ended 31 March 2020
3rd Jul 20205:03 pmRNSHolding(s) in Company
3rd Jul 20202:40 pmRNSNotice of Results & Investor Presentation
17th Jun 20205:45 pmEQSCORRECTION: Hardman & Co Research: Palace Capital presenting at virtual Investor Forum on 9th July 2020
17th Jun 20209:27 amEQSHardman & Co Research: Palace Capital presenting at virtual Investor Forum on 9th July 2020
27th Apr 20202:33 pmRNSDirector Dealing
27th Apr 202012:08 pmRNSSecond Price Monitoring Extn
27th Apr 202012:02 pmRNSPrice Monitoring Extension
17th Apr 20207:00 amRNSInvestor presentation
7th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20203:20 pmEQSHardman & Co Research: Palace Capital (PCA): Trading update and COVID-related dividend cut
2nd Apr 20207:00 amRNSCOVID-19 and dividend update
27th Mar 202010:09 amRNSDirector Dealing
10th Mar 20207:00 amRNSDividend Declaration
10th Feb 20204:40 pmRNSSecond Price Monitoring Extn
10th Feb 20204:35 pmRNSPrice Monitoring Extension
10th Feb 20207:00 amRNSRecord office rent in Hudson Quarter, York
3rd Feb 20207:00 amRNSAppointment of Non-Executive Director
27th Jan 202012:07 pmRNSSecond Price Monitoring Extn
27th Jan 202012:02 pmRNSPrice Monitoring Extension
8th Jan 202011:48 amRNSDirector dealing
12th Dec 201912:07 pmRNSSecond Price Monitoring Extn
12th Dec 201912:02 pmRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSPALACE CAPITAL DISPOSES OF BIRMINGHAM ASSET
27th Nov 20193:35 pmEQSHardman & Co Research: Palace Capital (PCA): 1H'20 results announced
19th Nov 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.